Face Transplant

A face transplant is a major surgery where a person's face is replaced. This is done when someone has lost their face due to injury or illness. The surgery involves taking skin, muscle, and bone from a donor and attaching it to the patient's face. It can help restore appearance and function.

Procedure

What people who've had Face Transplant report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Face Transplant

Who It's For

A face transplant replaces all or part of a person's face with tissue from a deceased donor. Depending on the injury, the transplant can include skin, fat, muscle, cartilage, nerves, blood vessels and sometimes bone, such as parts of the jaw or cheekbones. Surgeons connect the donor blood vessels and nerves to the recipient's own, so the tissue survives and can gradually regain feeling and movement. It is offered to a small number of people whose faces have been so severely damaged that they have lost important functions, such as eating, speaking, breathing through the nose or closing the lips, and whose injuries conventional surgery cannot adequately repair. Gunshot injuries and burns have been the most common causes; others include animal attacks, tumors such as those of neurofibromatosis, and differences present from birth. Since the first face transplant in 2005, only about 50 have been reported worldwide, at a handful of specialized centers. Many programs run as research protocols, and some US insurers, such as Aetna, classify the procedure as experimental. Most people with facial injuries are treated with conventional reconstruction, which moves the person's own tissue from elsewhere in the body, or with a facial prosthesis, a custom-made artificial part. These avoid lifelong anti-rejection medicine, but for the most extensive injuries they may not restore appearance and function as well as replacing the face as a whole. Unlike a heart or liver transplant, a face transplant is not life-saving. The decision weighs a possible large gain in function and quality of life against serious risks that can shorten life.

Before the Procedure

Evaluation takes months. The transplant team assesses physical health with detailed scans of the face and skull, such as CT (computed tomography) and MRI (magnetic resonance imaging), and with blood tests, and looks for infections and cancers that anti-rejection medicines could make worse. Swabs from the nose and mouth may be cultured to guide which infection-preventing medicines are used after surgery. A psychological evaluation explores coping skills, expectations, support from family and friends, and the ability to keep up with demanding care for life. Programs generally require that candidates not smoke, not misuse alcohol or drugs and not be pregnant, and they review the long-term costs of care with the person before approval. Once approved, the person joins a waiting list. A donor is matched on blood type and tissue type as well as skin tone, age and face size, so the wait is unpredictable. Candidates are usually asked to stay within a short trip of the hospital so they can arrive quickly when a donor becomes available, and to plan for living near the center for two to three months after surgery. The team needs to hear right away about new medicines, blood transfusions or new diagnoses, because transfusions in particular can make the immune system more likely to react against a donor and make a match harder to find.

During the Procedure

The operation takes roughly 10 to 30 hours, depending on how much of the face and its underlying structure is replaced, and the person is asleep under anesthesia throughout. Several teams work together, including plastic surgeons trained in microsurgery, the joining of tiny blood vessels and nerves under magnification. The damaged tissue is removed, the donor tissue is fitted and any donor bone is fixed in place. Surgeons then connect arteries and veins so blood flows into the new face, and join nerves that will slowly grow into it to restore sensation and muscle control. The result usually does not resemble the donor, because the new tissue settles over the recipient's own bone structure. Even so, neither the person nor the surgeons can predict exactly how the face will look.

Recovery & Aftercare

Hospital stays have ranged from about two weeks to two months. At first, nutrition usually comes through a feeding tube while swelling settles and the mouth heals. Anti-rejection medicines start immediately, along with medicines to prevent infection and control pain. Physical therapy and speech therapy begin as soon as the person is able, to retrain chewing, swallowing, speaking and facial expression. After discharge, most centers ask recipients to stay nearby for two to three months for frequent checkups. Function returns gradually because nerves grow slowly into the new tissue. In early cases, feeling to light touch, heat and cold came back within about six months, while movements such as fully closing the lips took closer to a year. The largest gains in sensation and movement have been seen around 18 months, with improvement continuing for years. Most recipients have regained or improved smell, eating, drinking, speech and some facial expression, although not everyone regains full movement. Adjusting emotionally to a new face is part of recovery, and mental health support continues alongside medical care. Follow-up is lifelong. Recipients take anti-rejection medicines every day, have regular blood tests and checkups, and sometimes have small biopsies of the facial skin or the lining of the mouth to look for rejection. Missing doses can lead to loss of the transplanted face. New swelling or a change in color of the transplanted face can signal rejection, and signs of infection matter more than usual on these medicines; either one is a reason to contact the transplant team promptly, because early treatment, sometimes with anti-rejection medicine given by vein in the hospital, can protect the graft.

Risks & Complications

The risks are serious and long-lasting, which is why face transplants are reserved for carefully chosen people. The operation itself can cause major blood loss, blood clots and infection. Rejection, in which the immune system attacks the donor tissue, is very common: about three in four recipients have had at least one acute episode, usually reversed with stronger medicine. A smaller number have developed chronic rejection, a slow loss of the tissue over years, and some recipients have lost part or all of the graft, occasionally needing a second transplant or conventional reconstruction. The lifelong anti-rejection medicines account for most of the long-term risk. By weakening the immune system, they make infections common, including viral infections such as cytomegalovirus (CMV) and fungal infections; about two in three face transplant recipients have had at least one such infection, and some have been severe. The medicines also raise the risk of certain cancers, diabetes, high blood pressure, high cholesterol and kidney damage. In one center that followed eight recipients for about six years, all had some decline in kidney function. Treating a serious infection or cancer can require lowering the medicines, which in turn raises the chance of rejection. Of about 50 face transplants reported worldwide, 10 recipients have died, most often from infection or cancer, and in a few cases from causes linked to mental health or difficulty keeping up with treatment. These figures come from a small number of early cases at different centers, so they may not reflect risk at an experienced program today, but they show why the trade-off must be discussed openly. People whose faces were damaged by extensive burns appear to face higher risks, including more rejection episodes, partly because earlier transfusions and skin grafts can sensitize the immune system. Psychological effects such as disappointment, regret or complicated feelings about the donor can also occur.

Questions to Ask Your Doctor

  1. 1.What could a face transplant realistically improve for me compared with further reconstruction or a prosthesis?
  2. 2.How many face transplants has your program performed, and how have those recipients done over the long term?
  3. 3.Which anti-rejection medicines would I take, and what side effects and monitoring should I expect for the rest of my life?
  4. 4.How long would I need to live near the center, and what support will I need at home during recovery?
  5. 5.Who pays for the surgery, the medicines and lifelong follow-up, and would it be done as part of a research study?

Last reviewed • Oct 2026

Educational content, not medical advice.